Life sciences and health technology
Home / Expertise / Life sciences and health technology

Life sciences and health technology

Our lawyers are renowned experts with extensive industry knowledge and highly specialized expertise in health regulatory rules and intellectual property rights.

Expertise in healthcare regulatory rules and intellectual property rights

Bull's team for life sciences and health technology consists of renowned lawyers with extensive industry knowledge. We possess highly specialized expertise in health regulatory rules, intellectual property rights, and other legal areas critical to players in this sector.

Our clients include companies in pharmaceuticals, biotechnology, medtech, and health technology, manufacturers of medical equipment, healthcare organizations, food and dietary supplement producers, public institutions, research environments, investors and acquirers.

Through memberships in Norway Health Tech, ALEAP, and The Life Sciences Cluster, we stay updated on industry trends and developments and actively contribute to knowledge sharing. Our lawyers also regularly provide expert commentary on Norwegian law in various international Life Sciences publications, including:

  • Immaterialretten i et nøtteskall, 2nd edition (2021), Gyldendal, co-author
  • The International Comparative Legal Guide to Drug & Medical Device Litigation Laws and Regulations (2021 and 2022), co-author
  • Pharmaceutical Advertising Laws and Regulations (2019 and 2020), chapter on Norway, ICLG, co-author
  • The Life Sciences Law Review, 7th Edition (2018), Norway, co-author
  • IAM Patents in Europe 2013/2014 (2013), co-author

Our services include, among other things:

  • Securing inventions, data, and assets through patents, trademarks and contracts.

  • We assist with collaboration agreements, R&D agreements, licensing agreements, various distribution agreements, manufacturing agreements and confidentiality agreements.

  • We advice on national and European rules for sales and marketing of pharmaceuticals, medical devices, dietary supplements and nutraceuticals.

  • Health technology and digitalization raise questions about data ownership, consent, and information security. We assist with compliance with frameworks for technology and security, such as the AI Act, GDPR and NIS2.

  • Representation in dialogue with the Norwegian Medicines Agency, the Norwegian Food Safety Authority, the Norwegian Data Protection Authority, the Norwegian Consumer Authority and the Norwegian Industrial Property Office.

  • The healthcare industry is impacted by competition rules and state aid regulations. We monitor regulatory developments and provide strategic advice.

  • We assist with M&A transactions, investment agreements, and structural changes in companies within pharmaceuticals, biotech, health technology and dietary supplements.

Expertise

All our expertise